India · Delayed Price · Currency is INR Galaxy Medicare Statistics
Total Valuation
Galaxy Medicare has a market cap or net worth of INR 266.27 million. The enterprise value is 175.12 million.
| Market Cap | 266.27M |
| Enterprise Value | 175.12M |
Important Dates
The next estimated earnings date is Friday, September 4, 2026.
| Earnings Date | Sep 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Galaxy Medicare has 15.17 million shares outstanding. The number of shares has increased by 28.05% in one year.
| Current Share Class | 15.17M |
| Shares Outstanding | 15.17M |
| Shares Change (YoY) | +28.05% |
| Shares Change (QoQ) | +55.72% |
| Owned by Insiders (%) | 57.14% |
| Owned by Institutions (%) | 1.85% |
| Float | 3.93M |
Valuation Ratios
The trailing PE ratio is 7.80.
| PE Ratio | 7.80 |
| Forward PE | n/a |
| PS Ratio | 0.67 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | 162.76 |
| P/OCF Ratio | 15.06 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.16, with an EV/FCF ratio of 107.04.
| EV / Earnings | 5.12 |
| EV / Sales | 0.44 |
| EV / EBITDA | 3.16 |
| EV / EBIT | 3.51 |
| EV / FCF | 107.04 |
Financial Position
The company has a current ratio of 4.24, with a Debt / Equity ratio of 0.10.
| Current Ratio | 4.24 |
| Quick Ratio | 2.87 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.76 |
| Debt / FCF | 25.68 |
| Interest Coverage | 18.00 |
Financial Efficiency
Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 11.59%.
| Return on Equity (ROE) | 10.60% |
| Return on Assets (ROA) | 7.76% |
| Return on Invested Capital (ROIC) | 11.59% |
| Return on Capital Employed (ROCE) | 12.01% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.00 |
| Inventory Turnover | 4.76 |
Taxes
In the past 12 months, Galaxy Medicare has paid 12.89 million in taxes.
| Income Tax | 12.89M |
| Effective Tax Rate | 27.38% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 18.90 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.77 |
| Average Volume (20 Days) | 8,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Galaxy Medicare had revenue of INR 400.03 million and earned 34.18 million in profits. Earnings per share was 2.25.
| Revenue | 400.03M |
| Gross Profit | 149.05M |
| Operating Income | 49.84M |
| Pretax Income | 47.07M |
| Net Income | 34.18M |
| EBITDA | 55.37M |
| EBIT | 49.84M |
| Earnings Per Share (EPS) | 2.25 |
Balance Sheet
The company has 133.16 million in cash and 42.01 million in debt, with a net cash position of 91.15 million or 6.01 per share.
| Cash & Cash Equivalents | 133.16M |
| Total Debt | 42.01M |
| Net Cash | 91.15M |
| Net Cash Per Share | 6.01 |
| Equity (Book Value) | 403.39M |
| Book Value Per Share | 21.80 |
| Working Capital | 236.33M |
Cash Flow
In the last 12 months, operating cash flow was 17.68 million and capital expenditures -16.04 million, giving a free cash flow of 1.64 million.
| Operating Cash Flow | 17.68M |
| Capital Expenditures | -16.04M |
| Depreciation & Amortization | 5.54M |
| Net Borrowing | -4.06M |
| Free Cash Flow | 1.64M |
| FCF Per Share | 0.11 |
Margins
Gross margin is 37.26%, with operating and profit margins of 12.46% and 8.54%.
| Gross Margin | 37.26% |
| Operating Margin | 12.46% |
| Pretax Margin | 11.77% |
| Profit Margin | 8.54% |
| EBITDA Margin | 13.84% |
| EBIT Margin | 12.46% |
| FCF Margin | 0.41% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 3.99%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 3.99% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 41.57% |
| Buyback Yield | -28.05% |
| Shareholder Yield | -24.06% |
| Earnings Yield | 12.84% |
| FCF Yield | 0.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |